Moving from rescue to prevention: real world evidence of reduction in IV antibiotic requirement following improvement in adherence to maintenance nebulised treatment in an adult cystic fibrosis centre by Hoo, Z.H. et al.
This is a repository copy of Moving from rescue to prevention: real world evidence of 
reduction in IV antibiotic requirement following improvement in adherence to maintenance 
nebulised treatment in an adult cystic fibrosis centre.




Hoo, Z.H., Curley, R., Carolan, C. et al. (4 more authors) (2015) Moving from rescue to 
prevention: real world evidence of reduction in IV antibiotic requirement following 
improvement in adherence to maintenance nebulised treatment in an adult cystic fibrosis 
centre. In: THORAX. British Thoracic Society Winter Meeting 2015, 2-4 December 2015, 





Unless indicated otherwise, fulltext items are protected by copyright with all rights reserved. The copyright 
exception in section 29 of the Copyright, Designs and Patents Act 1988 allows the making of a single copy 
solely for the purpose of non-commercial research or private study within the limits of fair dealing. The 
publisher or other rights-holder may allow further reproduction and re-use of this version - refer to the White 
Rose Research Online record for this item. Where records identify the publisher as the copyright holder, 
users can verify any specific terms of use on the publisher’s website. 
Takedown 
If you consider content in White Rose Research Online to be in breach of UK law, please notify us by 
emailing eprints@whiterose.ac.uk including the URL of the record and the reason for the withdrawal request. 
MOVING FROM RESCUE TO PREVENTION: REAL WORLD EVIDENCE OF REDUCTION 
IN IV ANTIBIOTIC REQUIREMENT FOLLOWING IMPROVEMENT IN ADHERENCE TO 

















ScHARR, University of Sheffield, Sheffield, UK 
2




Adherence to preventative nebulised therapy is associated with better health and lower costs for 
rescue treatment. However, adherence with nebulised treatment is generally poor and there is 
currently no systematic adherence intervention for people with CF. The Sheffield Adult CF centre 
has embarked on various pilot projects in this area, culminating in an NIHR programme grant 
awarded in 2014 to develop such a systematic adherence intervention. We hypothesised that the 
pilot projects would have improved the adherence levels and health outcomes among people with 




To determine overall change in nebuliser adherence and health outcomes among the cohort of 
people with CF in Sheffield from 2013 to 2014. Methods Demographic data, spirometry, BMI, 
annual total intravenous antibiotics days and prescription details were obtained by reviewing patient 
notes. Adherence was measured with I-neb nebuliser and calculated as a percentage of the agreed 
regimen between clinicians and people with CF. People on ivacaftor or with previous lung 




15 people were excluded from the analysis for both years. The cohort increased from n = 166 in 
2013 to n = 170 in 2014, with a similar increase in the number of people with Ineb data for 3 
months (n = 83 in 2013, n = 85 in 2014).  
 
Median nebuliser adherence 
improved from 40.5% in 
2013 to 49.5% in 2014.  
 
The median FEV1 remained 
stable at 79% while BMI 
improved slightly from 22.0 
in 2013 to 22.7 in 2014.  
 
The total IV days reduced by 
657 from 3970 in 2013 to 
3313 in 2014; a potential 






Although adherence remains a challenging issue, these data suggest the potential of benefits of 
improved adherence. More work will be needed to examine the adherence data in more detail and to 
collect further longitudinal data to determine if there is a clear trend of improvement. 
